Can Amgen (AMGN) Keep the Beat Streak Alive in Q4 Earnings?

We expect Amgen (AMGN) to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, after market close. In the last reported quarter, the company delivered an earnings surprise of 6.67%.Factors to ConsiderAmgen’s product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Prolia and Blincyto, among others. However, the prices of most products are expected to have declined.The Zacks Consensus Estimate for Prolia, Repatha, Evenity and B ...